vs

Side-by-side financial comparison of ESAB Corp (ESAB) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

ESAB Corp is the larger business by last-quarter revenue ($727.8M vs $455.6M, roughly 1.6× INNOSPEC INC.). INNOSPEC INC. runs the higher net margin — 10.4% vs 7.5%, a 2.9% gap on every dollar of revenue. On growth, ESAB Corp posted the faster year-over-year revenue change (8.5% vs -2.4%). ESAB Corp produced more free cash flow last quarter ($70.3M vs $46.8M). Over the past eight quarters, ESAB Corp's revenue compounded faster (2.8% CAGR vs -4.6%).

ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

ESAB vs IOSP — Head-to-Head

Bigger by revenue
ESAB
ESAB
1.6× larger
ESAB
$727.8M
$455.6M
IOSP
Growing faster (revenue YoY)
ESAB
ESAB
+10.9% gap
ESAB
8.5%
-2.4%
IOSP
Higher net margin
IOSP
IOSP
2.9% more per $
IOSP
10.4%
7.5%
ESAB
More free cash flow
ESAB
ESAB
$23.5M more FCF
ESAB
$70.3M
$46.8M
IOSP
Faster 2-yr revenue CAGR
ESAB
ESAB
Annualised
ESAB
2.8%
-4.6%
IOSP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ESAB
ESAB
IOSP
IOSP
Revenue
$727.8M
$455.6M
Net Profit
$54.8M
$47.4M
Gross Margin
37.0%
28.0%
Operating Margin
14.6%
10.3%
Net Margin
7.5%
10.4%
Revenue YoY
8.5%
-2.4%
Net Profit YoY
2.1%
167.3%
EPS (diluted)
$0.90
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESAB
ESAB
IOSP
IOSP
Q4 25
$727.8M
$455.6M
Q3 25
$715.6M
$441.9M
Q2 25
$678.1M
$439.7M
Q1 25
$440.8M
Q4 24
$670.8M
$466.8M
Q3 24
$673.3M
$443.4M
Q2 24
$707.1M
$435.0M
Q1 24
$689.7M
$500.2M
Net Profit
ESAB
ESAB
IOSP
IOSP
Q4 25
$54.8M
$47.4M
Q3 25
$66.9M
$12.9M
Q2 25
$67.4M
$23.5M
Q1 25
$32.8M
Q4 24
$53.7M
$-70.4M
Q3 24
$68.2M
$33.4M
Q2 24
$82.9M
$31.2M
Q1 24
$60.0M
$41.4M
Gross Margin
ESAB
ESAB
IOSP
IOSP
Q4 25
37.0%
28.0%
Q3 25
37.2%
26.4%
Q2 25
37.6%
28.0%
Q1 25
28.4%
Q4 24
38.5%
29.2%
Q3 24
37.7%
28.0%
Q2 24
38.2%
29.2%
Q1 24
37.0%
31.1%
Operating Margin
ESAB
ESAB
IOSP
IOSP
Q4 25
14.6%
10.3%
Q3 25
15.2%
1.3%
Q2 25
16.2%
7.8%
Q1 25
9.6%
Q4 24
16.6%
8.8%
Q3 24
15.7%
10.3%
Q2 24
16.9%
9.4%
Q1 24
16.0%
10.1%
Net Margin
ESAB
ESAB
IOSP
IOSP
Q4 25
7.5%
10.4%
Q3 25
9.3%
2.9%
Q2 25
9.9%
5.3%
Q1 25
7.4%
Q4 24
8.0%
-15.1%
Q3 24
10.1%
7.5%
Q2 24
11.7%
7.2%
Q1 24
8.7%
8.3%
EPS (diluted)
ESAB
ESAB
IOSP
IOSP
Q4 25
$0.90
$1.90
Q3 25
$1.09
$0.52
Q2 25
$1.10
$0.94
Q1 25
$1.31
Q4 24
$0.87
$-2.80
Q3 24
$1.11
$1.33
Q2 24
$1.35
$1.24
Q1 24
$0.98
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESAB
ESAB
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$218.2M
$292.5M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$2.1B
$1.3B
Total Assets
$4.9B
$1.8B
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESAB
ESAB
IOSP
IOSP
Q4 25
$218.2M
$292.5M
Q3 25
$258.2M
$270.8M
Q2 25
$291.3M
$266.6M
Q1 25
$299.8M
Q4 24
$249.4M
$289.2M
Q3 24
$253.7M
$303.8M
Q2 24
$228.5M
$240.2M
Q1 24
$76.5M
$270.1M
Total Debt
ESAB
ESAB
IOSP
IOSP
Q4 25
$1.3B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Q1 24
$992.8M
Stockholders' Equity
ESAB
ESAB
IOSP
IOSP
Q4 25
$2.1B
$1.3B
Q3 25
$2.1B
$1.3B
Q2 25
$1.9B
$1.3B
Q1 25
$1.3B
Q4 24
$1.8B
$1.2B
Q3 24
$1.8B
$1.2B
Q2 24
$1.7B
$1.2B
Q1 24
$1.6B
$1.2B
Total Assets
ESAB
ESAB
IOSP
IOSP
Q4 25
$4.9B
$1.8B
Q3 25
$4.4B
$1.8B
Q2 25
$4.2B
$1.8B
Q1 25
$1.8B
Q4 24
$4.0B
$1.7B
Q3 24
$4.1B
$1.8B
Q2 24
$4.0B
$1.7B
Q1 24
$3.8B
$1.7B
Debt / Equity
ESAB
ESAB
IOSP
IOSP
Q4 25
0.63×
Q3 25
0.51×
Q2 25
0.55×
Q1 25
Q4 24
0.60×
Q3 24
0.59×
Q2 24
0.63×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESAB
ESAB
IOSP
IOSP
Operating Cash FlowLast quarter
$81.5M
$61.4M
Free Cash FlowOCF − Capex
$70.3M
$46.8M
FCF MarginFCF / Revenue
9.7%
10.3%
Capex IntensityCapex / Revenue
1.5%
3.2%
Cash ConversionOCF / Net Profit
1.49×
1.30×
TTM Free Cash FlowTrailing 4 quarters
$238.0M
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESAB
ESAB
IOSP
IOSP
Q4 25
$81.5M
$61.4M
Q3 25
$46.6M
$39.3M
Q2 25
$35.4M
$9.3M
Q1 25
$28.3M
Q4 24
$126.9M
$25.7M
Q3 24
$101.0M
$73.5M
Q2 24
$83.0M
$4.7M
Q1 24
$44.5M
$80.6M
Free Cash Flow
ESAB
ESAB
IOSP
IOSP
Q4 25
$70.3M
$46.8M
Q3 25
$37.4M
$25.0M
Q2 25
$28.1M
$-3.7M
Q1 25
$19.9M
Q4 24
$102.2M
$13.6M
Q3 24
$90.4M
$65.8M
Q2 24
$74.0M
$-6.2M
Q1 24
$37.1M
$69.9M
FCF Margin
ESAB
ESAB
IOSP
IOSP
Q4 25
9.7%
10.3%
Q3 25
5.2%
5.7%
Q2 25
4.1%
-0.8%
Q1 25
4.5%
Q4 24
15.2%
2.9%
Q3 24
13.4%
14.8%
Q2 24
10.5%
-1.4%
Q1 24
5.4%
14.0%
Capex Intensity
ESAB
ESAB
IOSP
IOSP
Q4 25
1.5%
3.2%
Q3 25
1.3%
3.2%
Q2 25
1.1%
3.0%
Q1 25
1.9%
Q4 24
3.7%
2.6%
Q3 24
1.6%
1.7%
Q2 24
1.3%
2.5%
Q1 24
1.1%
2.1%
Cash Conversion
ESAB
ESAB
IOSP
IOSP
Q4 25
1.49×
1.30×
Q3 25
0.70×
3.05×
Q2 25
0.53×
0.40×
Q1 25
0.86×
Q4 24
2.36×
Q3 24
1.48×
2.20×
Q2 24
1.00×
0.15×
Q1 24
0.74×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESAB
ESAB

Consumable Products$477.9M66%
Equipment Products$249.9M34%

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

Related Comparisons